Mitesco (MITI) Cash from Discontinued Operations (2015 - 2023)

Mitesco's (MITI) quarterly Cash from Discontinued Operations came in at 268566.0 in Q4 2023, up 20.04% on a QoQ basis from 335881.0 in Q3 2023.

Mitesco (MITI) Cash from Discontinued Operations (2015 - 2023) Analysis & Trends

Mitesco (MITI) has 2 years of Cash from Discontinued Operations data on file, last reported at 268566.0 in Q4 2023.

On a quarterly basis, Cash from Discontinued Operations changed N/A year-over-year to 268566.0 in Q4 2023; TTM through Sep 2024 was 268566.0, a 47.95% increase from a year earlier, with the FY2023 full-year figure at 698611.0, up 82.84% from the prior year.
Cash from Discontinued Operations for Q4 2023 stood at 268566.0, up from 335881.0 in the prior quarter.
Over the last five years, Cash from Discontinued Operations for MITI reached as high as 302802.0 in Q1 2023 and fell as low as 396966.0 in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Discontinued Operations (Qtr)
1	Veeva Systems	32.00 Bn	24.69 Bn	662.02 Mn	-
2	BrightSpring Health Services	14.72 Bn	13.82 Bn	482.22 Mn	-
3	Healthequity	8.29 Bn	8.02 Bn	256.31 Mn	-
4	Hinge Health	5.99 Bn	5.67 Bn	154.23 Mn	-
5	10x Genomics	5.92 Bn	5.38 Bn	106.18 Mn	-
6	MiniMed	4.51 Bn	4.22 Bn	480.00 Mn	-
7	Waystar Holding	4.47 Bn	4.41 Bn	216.84 Mn	-
8	Doximity	3.95 Bn	3.20 Bn	125.97 Mn	-
9	Privia Health	3.15 Bn	2.73 Bn	-	-
10	Mitesco	861,250.76	859,717.76	-	-

Download Data